Following positive immunoassay screening, definitive confirmation testing identifies and quantifies tramadol in urine. This is essential because immunoassay screens can give false positives from cross-reactive substances, and clinical or legal decisions require accurate identification.
This test is used in workplace drug testing, addiction medicine, pain management compliance monitoring, and forensic settings. Sample type is urine, often under chain-of-custody protocols.